These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16299652)

  • 21. [Expression of X-linked inhibitor of apoptosis protein in colorectal cancer tissues].
    Li B; Zhang YD; Tian BN
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1746-8. PubMed ID: 18024305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
    Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
    Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
    Zhang H; Sun XF
    Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
    Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
    Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of glypican-3 in colorectal cancer].
    Yuan DH; Xie HH; Wang Y; Meng CY; Yang LP; Feng YC; Song JG; Zou X; Wu KC; Liu J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1540-2. PubMed ID: 18956635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
    Zhang N; Ding YQ; Liang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lymphatic infiltration identified by D2-40 monoclonal antibody predicts lymph node metastasis in submucosal invasive colorectal cancer.
    Kawaura K; Fujii S; Murata Y; Hasebe T; Ishii G; Itoh T; Sano Y; Saito N; Ochiai A
    Pathobiology; 2007; 74(6):328-35. PubMed ID: 18087197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of tissue inhibitor of metalloproteinase-1 in colorectal carcinoma and its clinical implications].
    Liu Y; Jiang B; Tong HS; Lai XR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):699-700. PubMed ID: 16762889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of FasL gene expression upon hepatic metastasis of colorectal carcinoma].
    Li SY; Yu B; An P; Wei JC; Zhang YN; Cai HY
    Zhonghua Wai Ke Za Zhi; 2003 Sep; 41(9):646-468. PubMed ID: 14680559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pak-1 expression increases with progression of colorectal carcinomas to metastasis.
    Carter JH; Douglass LE; Deddens JA; Colligan BM; Bhatt TR; Pemberton JO; Konicek S; Hom J; Marshall M; Graff JR
    Clin Cancer Res; 2004 May; 10(10):3448-56. PubMed ID: 15161701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.